Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione
- PMID: 9522357
- DOI: 10.1016/s0306-4522(97)00595-2
Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione
Abstract
Post-menopausal estrogen replacement therapy is associated with a reduction in the risk of Alzheimer's disease and has been reported to improve cognitive functioning in several small clinical trials. The present study evaluates the dependence of estrogenic neuroprotection on the presence of estrogen receptors using the murine neuronal cell line, HT-22, exposed to the neurotoxic beta-amyloid peptide. These cells lack functional estrogen receptors. The amyloid peptide killed 50-60% of these cells and concurrent treatment with either of three estratrienes, beta-estradiol, alpha-estradiol, or estratrien-3-ol, resulted in a dose-dependent protection. The potency of this estrogen neuroprotection was dependent on the presence of glutathione in the culture media. The presence of reduced glutathione in the media increases the neuroprotective potency of estrogens by an average of 400-fold. These results demonstrate that a nuclear estrogen receptor is not necessary for the neuroprotective actions of estrogens; however, the presence of an appropriate antioxidant in the extracellular milieu is needed for estratriene neuroprotection at physiologically and pharmacologically relevant doses. These data suggest the possibility of combined estrogen-antioxidant therapy for neurodegenerative diseases such as Alzheimer's disease.
Similar articles
-
Estradiol prevents amyloid-beta peptide-induced cell death in a cholinergic cell line via modulation of a classical estrogen receptor.Neuroscience. 2003;121(4):917-26. doi: 10.1016/s0306-4522(03)00464-0. Neuroscience. 2003. PMID: 14580942
-
Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.BMC Neurosci. 2006 Mar 13;7:24. doi: 10.1186/1471-2202-7-24. BMC Neurosci. 2006. PMID: 16533397 Free PMC article.
-
The synthetic estrogen 4-estren-3 alpha,17 beta-diol (estren) induces estrogen-like neuroprotection.Neurobiol Dis. 2005 Jun-Jul;19(1-2):331-9. doi: 10.1016/j.nbd.2005.01.011. Neurobiol Dis. 2005. PMID: 15837589
-
A novel mechanism of non-feminizing estrogens in neuroprotection.Exp Gerontol. 2017 Aug;94:99-102. doi: 10.1016/j.exger.2016.10.013. Epub 2016 Nov 3. Exp Gerontol. 2017. PMID: 27818250 Free PMC article. Review.
-
Neuroprotection by estradiol.Prog Neurobiol. 2001 Jan;63(1):29-60. doi: 10.1016/s0301-0082(00)00025-3. Prog Neurobiol. 2001. PMID: 11040417 Review.
Cited by
-
Cell Models for the Study of Sex Steroid Hormone Neurobiology.J Steroids Horm Sci. 2012;S2:003. doi: 10.4172/2157-7536.s2-003. J Steroids Horm Sci. 2012. PMID: 22860237 Free PMC article.
-
Protective Effects of Tualang Honey against Oxidative Stress and Anxiety-Like Behaviour in Stressed Ovariectomized Rats.Int Sch Res Notices. 2014 Sep 9;2014:521065. doi: 10.1155/2014/521065. eCollection 2014. Int Sch Res Notices. 2014. PMID: 27379299 Free PMC article.
-
The sex-specific interaction of the microbiome in neurodegenerative diseases.Brain Res. 2019 Dec 1;1724:146385. doi: 10.1016/j.brainres.2019.146385. Epub 2019 Aug 13. Brain Res. 2019. PMID: 31419428 Free PMC article. Review.
-
Potential use of estrogen-like drugs for the prevention of Alzheimer's disease.J Mol Neurosci. 2003;20(3):277-81. doi: 10.1385/JMN:20:3:277. J Mol Neurosci. 2003. PMID: 14501008 Review.
-
Cytoprotective effect of estrogen on ammonium chloride-treated C6-glioma cells.Neurochem Res. 2004 Jul;29(7):1359-64. doi: 10.1023/b:nere.0000026397.19836.0d. Neurochem Res. 2004. PMID: 15202765
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
